Fevara PLC
05 August 2026
5 August 2026
Fevara plc
("Fevara", the "Company", or the "Group")
Director/PDMR Shareholdings
Fevara plc (LSE: FVA), an international specialist in livestock supplements, announces that the following awards of options ("Options") were made on 03 August 2026 ("Award Date"), pursuant to the Company's Long Term Incentive Plan 2023 (the "LTIP"), to certain PDMRs over ordinary shares in the Company of 2.5p each ("Ordinary Shares"):
|
PDMR |
Number of Ordinary Shares |
|
Joshua Hoopes |
193,323 |
|
Gavin Manson |
53,535 |
The Options were awarded for nil-cost subject to the rules of the LTIP and will be exercisable from the third anniversary of the Award Date to the tenth anniversary of the Award Date. Following the development of the Group's medium-term strategic ambition to optimise performance, growth and shareholder returns, which was set out in the FY26 interim results announcement on 22 April 2026, the Remuneration Committee is keen to strengthen the link between the delivery of long-term sustained performance and Executive Director pay. Accordingly, and in accordance with the Directors' Remuneration Policy, the Committee has determined to award an increased level of share-based incentivisation for Joshua Hoopes and Gavin Manson for the Performance Period (as defined below).
Vesting of the Options is subject to performance targets based upon the Company's adjusted Earnings Per Share ("EPS") and relative Total Shareholder Return ("TSR") over a three-year performance period covering FY26, FY27 and FY28 ("Performance Period") as follows:
Adjusted EPS (75% weighting)
|
Threshold |
Maximum |
|
|
Target |
10% average annual growth in adjusted EPS |
15% average annual growth in adjusted EPS |
|
Vesting |
25% |
100% |
TSR (25% weighting)
|
Threshold |
Maximum |
|
|
Target |
Index Median |
Index Average Upper Quartile |
|
Vesting |
25% |
100% |
Vesting is adjusted on a straight-line basis between threshold and maximum targets.
Growth in adjusted EPS is calculated from a base adjusted EPS of 4.4p.
Growth in TSR is measured relative to the FTSE Small Cap Index (excluding investment trusts and financial services companies) during the Performance Period.
The following information is included in accordance with Article 19(3) of the Market Abuse Regulation (No. 596/2014):
|
||||
|
a) Name |
1. Joshua Hoopes 2. Gavin Manson |
|||
|
||||
|
a) Position/status |
1. Chief Executive Officer 2. Chief Financial Officer |
|||
|
b) Initial notification/Amendment |
Initial Notification |
|||
|
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) Name |
Fevara plc |
|||
|
b) LEI |
213800HTIKPQV98RA653 |
|||
|
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||
|
a) Description of the financial instrument, type of instrument |
Ordinary Shares of £0.025 each |
|||
|
b) Identification Code |
GB00BRK01058 |
|||
|
c) Nature of transactions |
Grant of award pursuant to the Company's Long Term Incentive Plan 2023 |
|||
|
d) Price(s) and Volume(s) |
Price(s) 1. Nil-Cost 2. Nil-Cost |
Volume(s) 193,323 53,535 |
||
|
e) Aggregated information: i. Aggregated volume ii. price |
N/A |
|||
|
f) Date of the transaction |
03 August 2026 |
|||
|
g) Place of the transaction |
Outside a trading venue |
|||
Enquiries:
|
Fevara plc Paula Robertson (Company Secretary) |
01228 554 600 |
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.